
The Wall Street Journal @WSJ
Eisai’s new Alzheimer’s disease drug Leqembi will be covered by the U.S. Department of Veterans Affairs, the first major insurer to agree to pay for the drug since its approval by regulators earlier this year https://t.co/hhLrBPLodp — PolitiTweet.org